IL2 and neoplasm: The combination of these three cytokines was based on the theory of improving antigen presentation with GM-CSF, expanding and activating T cells (LD-IL2+GM-CSF), increasing effector cell function (IFNα) and immunosensitising tumour cells by increased expression of HLA and adhesion molecules (IFNα).